BackStoke Therapeutics Overview
Stoke Therapeutics Inc

Stoke Therapeutics Target Price

Where could STOK trade next? Consensus target price: $51.

Get informed when a big investor buys or sells

+ Follow

Share Price

$28.43

Average Target Price

$51.0079.4% upside

2 analysts in the last 4 months

High: $58 | Low: $44

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-04Canaccord GenuitySumant Kulkarni$58104% upsideOpen
2026-07-13Goldman SachsKevin Strang$4454.8% upsideOpen
2026-02-23Wolfe Research$4040.7% upsideOpen
2026-02-05GuggenheimYatin Suneja$60111% upsideOpen
2026-01-12Wedbush$3626.6% upsideOpen
2026-01-05Canaccord Genuity$3626.6% upsideOpen
2026-01-05Loop Capital MarketsKeay Nakae$3523.1% upsideOpen
2025-12-16H.C. WainwrightAndrew Fein$5075.9% upsideOpen
2025-12-15UBS$5075.9% upsideOpen
2025-11-05Canaccord Genuity$281.5% downsideOpen
2025-10-10Needham$3523.1% upsideOpen
2025-08-18BTIGThomas Shrader$281.5% downsideOpen
2024-10-11Leerink PartnersMarc Goodman$1836.7% downsideOpen
2024-09-11H.C. WainwrightDebjit Chattopadhyay$3523.1% upsideOpen
2024-05-07Canaccord GenuitySumant Kulkami$2029.7% downsideOpen
2024-03-26NeedhamJoseph Stringer$2222.6% downsideOpen
2024-03-26Canaccord GenuitySumant Kulkami$2126.1% downsideOpen
2022-11-14Needham$2512.1% downsideOpen
2021-04-26Credit SuisseJudah Frommer$58104% upsideOpen

Stoke Therapeutics (STOK) FAQ

Stoke Therapeutics (STOK) currently reports a target price of $51. Use the charts on this page to explore Stoke Therapeutics's target price history and peer comparisons.

Analysts' average 12-month price target for Stoke Therapeutics is $51, about 79.4% upside from the current share price of $28.43. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $51, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Stoke Therapeutics, and consider following STOK for alerts when major investors trade the stock.

Stoke Therapeutics is classified in the Healthcare sector. On target price, it currently shows $51. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing STOK with unrelated industries.